ONCOVALUE Joins CS-AIW

ONCOVALUE Joins the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) Cluster

We are excited to announce that ONCOVALUE has officially joined the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) cluster, a European initiative focused on advancing cancer research through the application of artificial intelligence (AI).

The CS-AIW cluster brings together European projects dedicated to improving cancer outcomes. Through collaboration and shared expertise, this cluster aims to enhance the collective impact of AI-based solutions aimed at understanding, predicting, and improving the lives of cancer survivors. By aligning methodologies and coordinating communication efforts, the cluster fosters greater synergy among its members, strengthening the research community’s ability to address key challenges in cancer research.

The cluster addresses a wide range of important topics, including the use of real-world data, predictive modelling, personalised follow-up care, and strategies to improve quality of life for individuals living with and beyond cancer. These areas of focus are essential to developing effective, AI-driven solutions that can make a tangible difference in the lives of cancer survivors.

ONCOVALUE was introduced to the CS-AIW cluster during the meeting on Thursday, May 22, and is enthusiastic to be part of this collaborative network. We look forward to exchanging insights and expertise with other leading initiatives within the cluster. At the meeting, the Relevium project was presented, which aims to improve the quality of life for pancreatic cancer patients through AI-guided multimodal intervention plans. The project uses sensor data from wearable devices and smartphone apps to predict disease progression and deliver personalised interventions, ultimately enhancing the care experience for patients. Additionally, the cluster is currently working on a whitepaper that will outline its shared vision and strategic roadmap for integrating AI into cancer research. A follow-up event is scheduled for September, where members will continue to explore new developments and opportunities for collaboration.

As part of the ongoing efforts of the CS-AIW cluster, ONCOVALUE is committed to contributing to this dynamic network and collaborating with fellow members to accelerate progress. We are proud to be part of such an important initiative, and we are eager to provide updates on our work as our involvement in the cluster evolves. Stay tuned for more updates as we continue to drive innovation in cancer research. To learn more about the CS-AIW cluster, visit here.